Andrew J. Rech
- Oncology top 2%
- Immunology top 2%
- Molecular Biology
- Cancer Research
- Genetics
- Co-authors
- Robert H. VonderheideBen Z. StangerDavid BalliLee P. RichmanSusan M. DomchekJames L. RileyRosemarie MickTheresa A. Colligon
- Topics
- Immunotherapy and Immune Responses (13 papers)Cancer Immunotherapy and Biomarkers (11 papers)CAR-T cell therapy research (8 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- United StatesGermanySlovakia
In The Last Decade
Andrew J. Rech
22 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 1.1k
- Immunology 931
- Molecular Biology 418
- Cancer Research 155
- Genetics 131
Countries citing papers authored by Andrew J. Rech
This map shows the geographic impact of Andrew J. Rech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Rech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Rech more than expected).
Fields of papers citing papers by Andrew J. Rech
This network shows the impact of papers produced by Andrew J. Rech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Rech. The network helps show where Andrew J. Rech may publish in the future.
Co-authorship network of co-authors of Andrew J. Rech
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Rech. A scholar is included among the top collaborators of Andrew J. Rech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Rech. Andrew J. Rech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 12 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsbreakdown → | 104 |
| 7 | 82 | |
| 8 | 6 | |
| 9 | 0 | |
| 10 | 57 | |
| 11 | 114 | |
| 12 | 92 | |
| 13 | 88 | |
| 14 | 57 | |
| 15 | 176 | |
| 16 | 123 | |
| 17 | 271 | |
| 18 | 215 | |
| 19 | 32 | |
| 20 | 30 |
About Andrew J. Rech
Andrew J. Rech is a scholar working on Immunology, Oncology and Health Information Management, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (11 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Immunology (931 citations), Oncology (1.1k citations) and Cancer Research (155 citations). Andrew J. Rech has collaborated with scholars based in United States, Germany and Slovakia. Frequent co-authors include Robert H. Vonderheide, Ben Z. Stanger, David Balli, Lee P. Richman, Susan M. Domchek, James L. Riley, Rosemarie Mick, Theresa A. Colligon, Kevin R. Fox and Daniel J. Powell. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.